Related Experiment Video

Updated: Jun 25, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates

Published on: February 27, 2016

Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes

Shin-Ichiro Imai1, Wieland Kiess

  • 1Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110, USA. imaishin@wustl.edu

Frontiers in Bioscience (Landmark Edition)
|March 11, 2009
PubMed

Insights

Understanding the roles of SIRT1 and NAMPT-mediated NAD biosynthesis is crucial for type 2 diabetes treatment. These factors impact insulin secretion and beta cell function, offering potential therapeutic targets.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 2 diabetes pathogenesis involves complex genetic and environmental interactions.
  • Insulin secretion and sensitivity are key regulatory processes affected in type 2 diabetes.
  • Aging-associated decline in pancreatic beta cell function contributes significantly to type 2 diabetes.

Purpose of the Study:

  • To review the roles of SIRT1 and NAMPT-mediated NAD biosynthesis in glucose homeostasis.
  • To explore the involvement of these pathways in type 2 diabetes pathophysiology.
  • To discuss the potential of SIRT1 and NAMPT as therapeutic targets for type 2 diabetes.

Main Methods:

  • Literature review of studies on SIRT1 and NAMPT in glucose metabolism.
  • Analysis of research on NAD biosynthesis and its relation to pancreatic beta cell function.
  • Synthesis of findings regarding the link between these pathways and type 2 diabetes.

Main Results:

  • SIRT1 and NAMPT-mediated NAD biosynthesis are critical for regulating glucose homeostasis.
  • These pathways influence glucose-stimulated insulin secretion in pancreatic beta cells.
  • Dysregulation of SIRT1 and NAMPT contributes to age-related beta cell dysfunction and type 2 diabetes.

Conclusions:

  • SIRT1 and NAMPT play significant roles in maintaining glucose balance and beta cell health.
  • Targeting SIRT1 and NAMPT-mediated NAD biosynthesis presents a promising strategy for type 2 diabetes prevention and treatment.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...